Literature DB >> 8266010

Decrease of ischaemia-reperfusion related lung oedema by continuous ventilation and allopurinol in rat perfusion lung model.

M Okuda1, K Furuhashi, Y Nakai, M Muneyuki.   

Abstract

Using isolated perfusion rat lung model, we studied the effect of continuous ventilation without perfusion and allopurinol on the development of ischaemia-reperfusion lung injury. Ischaemia was induced by stopping the perfusion. Normothermic ischaemia for 90 min without ventilation caused significant lung oedema. Continuous ventilation during ischaemia with 21% O2 decreased lung oedema significantly after 60 min of reperfusion. The same protection could be achieved by 100% N2 ventilation during 90 min of ischaemia, suggesting that xanthine oxidase (XO) is unlikely to cause the ischaemia-reperfusion lung injury. On the other hand allopurinol, XO inhibitor, equally inhibited lung oedema after 90 min of ischaemia and 60 min of reperfusion. These results indicate that mechanical movement of alveoli provides successful preservation of ischaemic lung, and allopurinol has some protective effect other than XO inhibition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266010

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

Review 1.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

2.  Attenuation of ischemia reperfusion-induced lung edema by prostaglandin I2 analogue OP-2507 in the isolated perfused rat lung.

Authors:  Masahiro Okuda; Kazuhisa Furuhashi; Yasushi Nakai; Homare Amano; Mannosuke Muneyuki
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

Review 3.  Prevention of lung injury in cardiac surgery: a review.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2014-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.